CTNM Contineum Therapeutics, Inc. Class A Common Stock

Healthcare

$13.70-1.15%ClosedMarket Cap: $512.2M

As of 2026-05-26

Valuation

P/E (TTM)

—

PEG

—

P/B

2.07

P/S

0.00

EV/EBITDA

-7.80

DCF Value

$2.40

FCF Yield

-11.1%

Div Yield

0.0%

Margins & Returns

Gross Margin

0.0%

Operating Margin

0.0%

Net Margin

0.0%

ROE

-27.1%

ROA

-22.4%

ROIC

-26.0%

Income Statement

Periods shown are fiscal year quarters (may differ from calendar year)

Period	Revenue	Gross Margin	Operating Income	Net Income	EPS	Dividend
Q1 null	$0.00	NaN%	$-16.9M	$-14.5M	$—	—
Q4 null	$0.00	NaN%	$-17.1M	$-15.2M	$—	—
FY null	$0.00	NaN%	$-68.1M	$-60.0M	$—	—
Q3 null	$0.00	NaN%	$-14.9M	$-12.8M	$—	—
Q2 null	$0.00	-Infinity%	$-17.9M	$-16.0M	$—	—
Q1 null	$0.00	NaN%	$-18.1M	$-16.0M	$—	—
Q4 null	$0.00	NaN%	$84.7M	$-14.6M	$—	—
FY null	$0.00	-Infinity%	$-50.9M	$-42.3M	$—	—
Q3 null	$0.00	NaN%	$-13.0M	$-10.3M	$—	—
Q2 null	$0.00	NaN%	$-10.9M	$-9.0M	$—	—
Q1 null	$0.00	NaN%	$-9.9M	$-8.4M	$—	—
Q4 2023	$0.00	NaN%	$-9.7M	$-7.8M	$-0.31	—